Off to a Good Start in Fiscal 2024

The positive development of Healthcare and Electronics largely compensated for the decline in Life Science.

Key facts and Forecast

Financial results of Q1 2024

  • Healthcare with strong performance
  • Electronics increases sales and earnings organically, driven by higher demand for semiconductor materials
  • Inventory destocking in Life Science continues; sales recovery expected in the second half of the year
  • Net sales down organically by 1.2% to € 5.1 billion
  • EBITDA pre decreases organically by 5.2% to € 1.5 billion

Forecast for fiscal 2024

  • Qualitative guidance confirmed with Merck KGaA, Darmstadt, Germany returning to organic growth
  • Net sales: in a range of € 20.6 billion to € 22.1 billion, organically +1% to +5%
  • EBITDA pre: in a range of € 5.7 billion to € 6.3 billion, organically +1% to +7%

Overview: business performance in Q1 2024

 

Q1 2024               (in € billion)

Change (in %, compared to Q1 2023)

Organic change  (in %, compared to     Q1 2023)

Group net sales

5.1          

-3.3

-1.2

EBITDA pre

1.5          

‑8.4

‑5.2

Life Science sales

2.1

-13.8

-12.6

Healthcare sales

2.0

7.5

10.1

Electronics sales

0.9

3.1

6.3

Belén Garijo - Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany Belén Garijo - Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

We had a good start to the year and gained initial momentum in the first quarter of 2024, once again benefiting from our diversified business model. We expect acceleration in the second half of the year, especially in Life Science, and thus a gradual return to organic growth for the Group in fiscal 2024.

Belén Garijo

Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

Conference calls for the media and analysts

Related News

View All News
  1. Press Releases

    Off to a Good Start in Fiscal 2024

    The positive development of Healthcare and Electronics largely compensated for the decline in Life Science.

    2024/05/15

Upcoming Events

View All Events

Esther Döringer

Financial Communications

Constantin Fest

Head of Investor Relations

+49 6151 72-5271

+49 6151 72 91-5271

Annual Reports Archive

Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more

Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.

Check Share Price